Document is current

Any future updates will be listed below

Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood

Crossref DOI link: https://doi.org/10.1007/s00277-025-06226-z

Published Online: 2025-02-01

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark